Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy

NCT07632768 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis (CF)
Pancreatic Insufficiency
Pancreas Disease
Exocrine Pancreatic Insufficiency
Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
CFTR Gene Mutation

Interventions

DRUG: Discontinuation of Pancreatic Enzyme Replacement Therapy

Sponsor

Indiana University

Collaborators

[object Object]